VWM
REGN icon

Venturi Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Venturi Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-612
Closed -$388K – 600
2025
Q1 		$388K Buy
612
+267
+77% +$184K 0.02% 380
2024
Q4 		$246K Sell
345
-177
-34% -$149K 0.01% 495
2024
Q3 		$549K Buy
522
+5
+1% +$5.56K 0.03% 280
2024
Q2 		$543K Buy
517
+23
+5% +$22.3K 0.03% 270
2024
Q1 		$475K Sell
494
-3
-0.6% -$2.85K 0.03% 270
2023
Q4 		$437K Buy
497
+70
+16% +$57.6K 0.03% 274
2023
Q3 		$351K Sell
427
-20
-4% -$15.7K 0.03% 273
2023
Q2 		$321K Buy
447
+47
+12% +$36.2K 0.03% 263
2023
Q1 		$329K Sell
400
-35
-8% -$26.4K 0.03% 271
2022
Q4 		$314K Buy
435
+90
+26% +$66.4K 0.03% 276
2022
Q3 		$237K Sell
345
-26
-7% -$16.4K 0.02% 292
2022
Q2 		$219K Sell
371
-215
-37% -$140K 0.02% 296
2022
Q1 		$409K Sell
586
-29
-5% -$18.3K 0.03% 262
2021
Q4 		$388K Sell
615
-11
-2% -$6.76K 0.03% 266
2021
Q3 		$379K Sell
626
-99
-14% -$61.5K 0.03% 254
2021
Q2 		$405K Sell
725
-304
-30% -$154K 0.04% 248
2021
Q1 		$487K Sell
1,029
-53
-5% -$25.8K 0.05% 228
2020
Q4 		$523K Sell
1,082
-109
-9% -$58.8K 0.05% 215
2020
Q3 		$666K Buy
1,191
+574
+93% +$348K 0.08% 169
2020
Q2 		$385K Sell
617
-34
-5% -$19.3K 0.05% 209
2020
Q1 		$318K Sell
651
-4
-0.6% -$1.65K 0.05% 179
2019
Q4 		$246K Buy
+655
New +$220K 0.03% 220
2019
Q3 		– Sell
-656
Closed -$205K – 245
2019
Q2 		$205K Buy
656
+12
+2% +$4K 0.03% 238
2019
Q1 		$264K Sell
644
-5
-0.8% -$2.06K 0.03% 218
2018
Q4 		$241K Buy
649
+19
+3% +$6.95K 0.04% 229
2018
Q3 		$248K Hold
630
– – 0.04% 155
2018
Q2 		$234K Buy
+630
New +$197K 0.04% 160
2017
Q3 		– Sell
-422
Closed -$207K – 194
2017
Q2 		$207K Buy
+422
New +$185K 0.05% 176

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Venturi Wealth Management's REGN Position: Q2 2025 in Review

Venturi Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 612 shares — an estimated $388K sold.

Venturi Wealth Management first reported a position in REGN in Q2 2017 and held it in 28 quarters. The position peaked at $666K in Q3 2020. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Venturi Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 612 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $388K.
  • Venturi Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2017 and held it in 28 quarters.
  • Venturi Wealth Management's Regeneron Pharmaceuticals position peaked at $666K in Q3 2020.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Venturi Wealth Management's 13F filing for Q2 2025, filed 23 Jul 2025.